The holder of a manufacturing authorisation must manufacture medicinal products so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorisation and do not place patients at risk due to inadequate safety, quality or efficacy. The attainment of this quality objective is the responsibility of senior management and requires the participation and commitment by staff in many different departments and at all levels within the company, by the company’s suppliers and by the distributors. To achieve the quality objective reliably there must be a comprehensively designed and correctly implemented system of Quality Assurance Incorporating Good Manufacturing Practice, and thus Quality Control and Quality Risk Management. It should be fully documented and its effectiveness monitored. All parts of the Quality Assurance systems should be adequately resourced with competent personnel, and suitable and sufficient premises, equipment and facilities. There are additional legal responsibilities for the holder of the manufacturing authorisation and for the authorised person Keywords: Good Manufacturing Practice, Quality control, Quality assurance, authorised
CITATION STYLE
Shukla, A., Vishnoi, G., & Das, D. R. (2016). CURRENT GOOD MANUFACTURING GUIDELINES FOR MEDICINAL PRODUCT. Journal of Drug Delivery and Therapeutics, 6(2). https://doi.org/10.22270/jddt.v6i2.1201
Mendeley helps you to discover research relevant for your work.